Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rhythm Pharmaceuticals Announces European Commission Expansion Of IMCIVREE Marketing Authorization To Include Children Aged 2-5 With Obesity Due To Bardet Biedl Syndrome Or POMC, PCSK1, And LEPR Deficiency

Author: Benzinga Newsdesk | July 31, 2024 09:11am

Posted In: RYTM VGK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist